Rheumatoid Arthritis

Treating Rheumatoid Arthritis – A Roll of the Dice

24 Nov 2020

Posted at 13:21h in Rheumatoid Arthritis, Rheumatoid Arthritis Research, The ANRF Chronicle by ANRF 0 Comments

Share

Dr. Noss is an assistant professor, division of rheumatology, Roosevelt Clinic, University Washington Medical Center. Dr. Noss received her MD as well as her PhD in 2002 from Case Western Reserve University. She completed her residency in internal medicine in 2004 and her fellowship in...

Read More

Christian Lood – A Complement to RA Research

24 Sep 2020

Posted at 13:37h in Rheumatoid Arthritis, Rheumatoid Arthritis Research, The ANRF Chronicle by ANRF 0 Comments

Share

Dr. Lood completed both his Master’s degree in biomedicine and his PhD in Clinical Medicine at Lund University. At this early stage in his career, he was already marked as a researcher to watch and was awarded the best doctoral thesis of the year. After...

Read More

Dr. Mattias Svensson – RA Leads to Loss of our Natural Protection

24 Apr 2020

Posted at 11:03h in Rheumatoid Arthritis, Rheumatoid Arthritis Research, The ANRF Chronicle by ANRF 0 Comments

Share

Dr. Mattias Svensson obtained both his MS, in pharmacy and pharmacology, and PhD, in medicine, from the University of Gothenburg, Sweden. In 2014 he was recruited as a postdoctoral fellow to a laboratory at the La Jolla Institute for Immunology. In 2016 the head of...

Read More

Potential COVID-19 Treatments – RA and Other Disease Drugs

23 Apr 2020

Posted at 16:18h in Rheumatoid Arthritis, Rheumatoid Arthritis Research, The ANRF Chronicle by ANRF 0 Comments

Share

These are only experimental efforts and none of these compounds are validated or sanctioned by health authorities for the treatment of COVID-19. As the COVID-19 pandemic rages on, the world is desperate for good news in regards to effective treatments. As of the first week of...

Read More

Theresa Wampler Muskardin – Profiling RA for Personalised Treatment

25 Feb 2020

Posted at 14:41h in Rheumatoid Arthritis, Rheumatoid Arthritis Research, The ANRF Chronicle by ANRF 0 Comments

Share

Dr. Theresa Wampler Muskardin is a junior faculty member at New York University School of Medicine. She received her medical degree from Wayne State University School of Medicine in 2004 and specializes in Rheumatology. Her goal as a researcher is to one day be able...

Read More

ANRF Alumni Award Winner at ACR 2019 Conference

17 Dec 2019

Posted at 15:40h in Rheumatoid Arthritis, Rheumatoid Arthritis Research, The ANRF Chronicle by ANRF 0 Comments

Share

This November, thousands of medical professionals in the field of rheumatology gathered in Atlanta, Georgia to collaborate, learn, and celebrate the achievements of their colleagues. Each year, from a cohort of thousands of ACR physicians, health professionals, and scientists, a handful of exceptional people have the...

Read More

Treating Rheumatoid Arthritis – A Challenge

16 Sep 2019

Posted at 11:38h in Rheumatoid Arthritis, The ANRF Chronicle by ANRF 0 Comments

Share

Dr Noss is an assistant professor, division of rheumatology, Roosevelt Clinic, University Washington Medical Center. Dr Noss received her MD as well as her PhD in 2002 from Case Western Reserve University. She completed her residency in internal medicine in 2004 and her fellowship in...

Read More

A Brief History of Rheumatoid Arthritis

16 Sep 2019

Posted at 09:38h in Rheumatoid Arthritis, The ANRF Chronicle by ANRF 0 Comments

Share

A Disease as Old as Time More than 2300 years ago the father of modern medicine, Hippocrates, was quoted saying “It is incredible how fast the mischief spreads.” In saying this Hippocrates was referring to a condition arthritic in nature, with an onset occurring in...

Read More

No Smoke Without Fire – Environmental Factors Affecting RA

16 Sep 2019

Posted at 09:21h in Rheumatoid Arthritis, The ANRF Chronicle by ANRF 0 Comments

Share

The development of autoimmune diseases is often dependent on an interaction between a patient’s genetic makeup combined with environmental risk factors. The onset of the clinical presentation of the disease occurs once a threshold has been reached with an accumulative effect from both genetic and...

Read More

New AbbVie RA Drug Approved by the FDA

16 Sep 2019

Posted at 09:12h in Rheumatoid Arthritis, The ANRF Chronicle by ANRF 0 Comments

Share

Humira, generically known as adalimumab, has been the gold standard for treatment of RA particularly in patients that have not responded to other forms of treatment. In 2016 4 million prescriptions for Adalimumab were given out. This is a biologic drug and like other TNF...

Read More